| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |